Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease (Q39678301)
Jump to navigation
Jump to search
scientific article published on 19 July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease |
scientific article published on 19 July 2010 |
Statements
1 reference
Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease (English)
1 reference
Soken-Nakazawa J Song
1 reference
Naohisa Tomosugi
1 reference
Hiroshi Kawabata
1 reference
Takayuki Ishikawa
1 reference
Teppei Nishikawa
1 reference
Kazuyuki Yoshizaki
1 reference
19 July 2010
1 reference
3627-3634
1 reference
Identifiers
1 reference